Pfizer prices >$1bn debt offering


Pfizer have announced the pricing of $1,065,000,000 aggregate principal amount of 4.20% notes due 2047

This offering is expected to be sold to professional institutional investors in Taiwan, with application to be made to list the notes on the Taipei Exchange.

Pfizer intends to use the net offering proceeds for general corporate purposes, including to repay a portion of its outstanding commercial paper.

The closing of the offering is expected to occur on March 17, 2017, subject to satisfaction of customary closing conditions.

BNP Paribas, Taipei Branch and Deutsche Bank AG, Taipei Branch are acting as joint book-running managers for the offering. Acting as structuring agents for the offering are:

  • Deutsche Bank (Taipei Branch)
  • Citigroup Global Markets
  • HSBC Securities USA
  • Mizuho Securities USA
  • Morgan Stanley
  • Standard Chartered Bank
  • Academy Securities
  • Seibert Cisneros Shank
  • The Williams Capital Group

Each structuring agent (other than Deutsche Bank Taipei Branch), is an entity not licensed in the Republic of China, has not offered or sold, and will not subscribe for or sell or underwrite, any of the notes.

Sign up for your free email newsletter

The offering of these securities is being made only by means of a prospectus. Copies may be obtained by calling BNP Paribas, Taipei Branch at 1-800-854-5674 or Deutsche Bank AG, Taipei Branch at 1-800-503-4611.